CMBA
AGL icon

C.M. Bidwell & Associates’s Agilon Health AGL Stock Holding History

C.M. Bidwell & Associates’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6K Buy
+56
New +$3.67K ﹤0.01% 320

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

C.M. Bidwell & Associates's AGL Position: Q2 2026 in Review

C.M. Bidwell & Associates opened a new position in Agilon Health (AGL) in Q2 2026: 56 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #320 among its holdings.

179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • C.M. Bidwell & Associates held 56 shares of Agilon Health worth $6K as of Q2 2026.
  • Agilon Health was a new C.M. Bidwell & Associates position in Q2 2026.
  • Agilon Health made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #320 holding.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.